Question 1

Can you build the model investors ask for, with reimbursement, sales cycles and cash to break-even?

Accepted Answer

Yes. Alehar builds the model that ties the development plan, the trials, the approval timeline, the reimbursement in each market, the hospital sales cycle and the margin per unit into one cash forecast, with the first revenue placed where the evidence puts it. The model is reviewed with the founders each month and becomes the base of the investor pack and the data room.

Question 2

A strategic has offered to fund our next trial in return for distribution rights. Can you assess what we would give up?

Accepted Answer

Yes. Alehar models the offer on its terms: the funding, the territories and the term of the distribution rights, the margin the partner keeps, the minimums it commits to and the options it takes on the company, against funding the trial with equity or venture debt and selling direct later. The founders see what the deal costs in each market before they sign, and Alehar supports the negotiation.

Question 3

Our investors want us to raise venture debt alongside the round. Can you show whether we can carry it?

Accepted Answer

Yes. Alehar sets the proposed facility against the forecast: the repayments, the minimum cash and milestone covenants, the warrants and what happens if approval slips by a year. It shows the month the debt would bite under a slower case and compares it with a larger equity round. Alehar negotiates the terms as part of its Raising Equity or Debt service.

Question 4

Can you price the device against what the hospital is actually reimbursed?

Accepted Answer

Yes. Alehar builds the pricing from what the hospital or the insurer is paid for the procedure the device is used in, by market, rather than from the list price, and shows the margin after the distributor's share, freight, warranty, service and consignment stock. Where reimbursement is not yet in place, the forecast shows what the company must fund until it is.

Question 5

Can you tell us what the device will cost to make at volume?

Accepted Answer

Yes. Alehar builds the unit cost from the bill of materials, the contract manufacturer's quotes, yield and testing, with fixed costs spread over the planned volume, and shows what the cost does as volume rises, which components drive it and what the first batches really cost against plan. Founders see the price the device needs, the volume where it makes money and when to move manufacturing.

Question 6

Our hospital sales cycle is nine months. Can you plan cash and hiring around it?

Accepted Answer

Yes. Alehar forecasts the pipeline by stage, from first evaluation to committee approval, purchase order and payment, with each stage given the time it has actually taken. It shows what the business can afford to spend on sales staff while the pipeline converts, the cash tied up in evaluation units and consignment stock, and when each sales hire pays for itself.

Question 7

Can you prepare us for a sale to a larger player when the time comes?

Accepted Answer

Yes. Alehar prepares what a larger buyer will test: the approvals and the evidence behind them, the product-by-product profit history, the recurring revenue from consumables, the margin per unit and the forecast, in a data room built as the company grows rather than in the month of the approach. When the founders decide to sell, Alehar runs the process under its Selling your Company service. The founders and their advisers handle the technical and clinical questions.

Question 8

Would an outsourced or virtual CFO suit a medtech startup that is years from profit?

Accepted Answer

Yes, for most medical device companies, diagnostics device makers and medtech startups between the seed round and the hire of a full-time CFO. Alehar provides a partner and a team, reviews runway, development spend, margin and pipeline with the founders each month and brings extra support in a round, a strategic deal or a sale. It is what founders look for in an interim CFO, a virtual CFO or a fractional FD. Your accountant still runs the books, and Alehar builds the forecast and the investor reporting on them.

Fractional CFO for Medtech and Medical Device Companies

What medtech founders tell us

Why medtech and medical device companies work with Alehar

A partner who is accountable

A complete team, not a single hire

Month to month, without lock-in

The same partner for the raise or the sale

Start maximizing the potential of your company now.

We get you a true financial picture of your company

We help you save costs and improve cashflow

We develop effective plans to help you grow revenue

We help you identify and decide between growth initiatives

We get you ready for an investment or a sale

The same work, already done.

Project Vita

Project Axis

Project Zenith

Frequently asked questions

Tools for medtech finance decisions

Valuation Calculator

Debt Capacity Calculator

Events Directory

Let's connect.

Sign up for our insights